VBI Vaccines Inc VBIV:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
Last | 9:42 AM EDT
0.5975quote price arrow up+0.0175 (+3.0172%)
Volume
4,983
52 week range
0.45 - 10.47
Loading...
  • Open0.61
  • Day High0.61
  • Day Low0.59
  • Prev Close0.58
  • 52 Week High10.47
  • 52 Week High Date03/30/23
  • 52 Week Low0.45
  • 52 Week Low Date10/25/23

Key Stats

  • Market Cap14.153M
  • Shares Out23.69M
  • 10 Day Average Volume0.06M
  • Dividend-
  • Dividend Yield-
  • Beta1.91
  • YTD % Change0.43

KEY STATS

  • Open0.61
  • Day High0.61
  • Day Low0.59
  • Prev Close0.58
  • 52 Week High10.47
  • 52 Week High Date03/30/23
  • 52 Week Low0.45
  • 52 Week Low Date10/25/23
  • Market Cap14.153M
  • Shares Out23.69M
  • 10 Day Average Volume0.06M
  • Dividend-
  • Dividend Yield-
  • Beta1.91
  • YTD % Change0.43

RATIOS/PROFITABILITY

  • EPS (TTM)-83.09
  • P/E (TTM)-0.01
  • Fwd P/E (NTM)-0.77
  • EBITDA (TTM)-62.353M
  • ROE (TTM)-221.45%
  • Revenue (TTM)8.122M
  • Gross Margin (TTM)-58.77%
  • Net Margin (TTM)-1,403.15%
  • Debt To Equity (MRQ)252.94%

EVENTS

  • Earnings Date-
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On VBI Vaccines Inc

 

Content From Our Affiliates

There is no recent news for this security.

Profile

MORE
VBI Vaccines Inc. is a commercial stage biopharmaceutical company. Through its approach to virus-like particles (VLPs), including an enveloped VLP (eVLP) platform technology, The Company develops vaccine candidates that mimic the natural presentation of viruses, designed to elicit the innate power of the human immune system. The Company is focused on targeting and overcoming infectious diseases, including hepatitis B (HBV), COVID-19, and coronaviruses, and cytomegalovirus...
Steven Gillis Ph.D.
Independent Chairman of the Board
Jeffrey Baxter
President, Chief Executive Officer, Director
Nell Beattie
Chief Financial Officer, Director, Head of Corporate Development
Address
160 Second Street, Cambridge
Cambridge, MA
02142
United States

Top Peers

SYMBOLLASTCHG%CHG
EDSA
Edesa Biotech Inc
4.44-0.01-0.22%
ATE
AEZS
Aeterna Zentaris Inc
2.05-0.03-1.44%
PRTG
Portage Biotech Inc
0.55+0.01+1.8519%
KTRA
Kintara Therapeutics Inc
0.101+0.0115+12.8492%